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Abstract
Background: The regulatory management of chemicals and toxicants in the EU addresses hundreds of different
chemicals and health hazards individually, one by one. An issue is that, so far, the possible interactions among
chemicals or hazards are not considered as such. Another issue is the anticipated delay of several decades before
effective protection of public health by regulatory decisions due to a time consuming process. Prenatal and early
postnatal life is highly vulnerable to environmental health hazards with lifelong consequences, and a priority period
for reduction of exposure. There are some initiatives regarding recommendations for pregnant women aiming at
protection against one or another category of health hazard, however not validated by intervention studies.
Hypothesis: Here, we aim at strengthening the management of exposure to individual health hazards during pregnancy
and lactation, with protective measures in a global strategy of Environmental Hygiene. We hypothesize that such a
strategy could reduce both the individual effects of harmful agents in complex mixtures and the possible interactions
among them. A panel of experts should develop and endorse implementable measures towards a protective behavior.
Their application is meant to be preferably as a package of measures in order to maximize protection and minimize
interactions in causing adverse effects. Testing our hypothesis requires biomonitoring studies and longitudinal evaluation
of health endpoints in the offspring. Favorable effects would legitimate further action towards equal opportunity access
to improved environmental health.
Conclusion: Environmental Hygiene is proposed as a global strategy aiming at effective protection of pregnant women,
unborn children and infants against lifelong consequences of exposure to combinations of adverse lifestyle factors.
Keywords: Pregnancy, Mutagens, Endocrine disrupting chemicals, Carcinogens, Precautionary principle, Public health,
Developmental origin of health and disease
Background
Prenatal/neonatal exposures and lifelong consequences
For about four decades, the human population has been ex-
posed to an increasingly large array of synthetic chemicals.
Only about 1% of those chemicals have been studied so far
since scientific research is time-consuming and costly [1].
They include mutagens, Endocrine Disrupting Chemicals
(EDCs), carcinogens and teratogens that may cause life-
long harm depending on life period and level of exposure
among other factors [2]. Past findings and derived concepts
indicate that several adult diseases represent late onset con-
sequences of early exposures [3–6]. A pioneering dramatic
illustration was the occurrence of vaginal cancer and repro-
ductive disorders in the offspring of mothers treated with
diethylstilbestrol during pregnancy [3, 7]. Here, transge-
nerational and other studies point toward involvement of
epigenetic mechanisms [8]. Another pioneering observation
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was the possible fetal origin of testicular cancer [9, 10]. This
provided the basis of the Testicular Dysgenesis Syndrome
linking delay in differentiation of fetal testes with lifelong
consequences including reduced sperm quality and testicu-
lar cancer [4]. Early exposures to EDCs can have huge
impact on development and on the risk of diseases such as
adult reproductive failure, cancer, obesity, diabetes and
metabolic syndrome, and neurodevelopmental disorders
among others [11]. Fetal exposure to dietary carcinogens
seems to induce molecular events that indicate increased
cancer risks together with other adverse health effects such
as reduced birth weight and head circumference [5]. Child-
hood cancer, in particular leukemia among boys, can be
causally related to the maternal dietary intake of carcino-
genic substances during pregnancy [5]. Fetal exposure to
mutagens such as polycyclic aromatic hydrocarbons also
increases the risk of cancer and neurodevelopmental disor-
ders [12]. Telomeres, markers of biological ageing are
highly variable at birth and it has been identified recently
that maternal exposures to air pollution is associated with
telomere length of the next generation [13]. Taken together,
those data demonstrate some causal mechanisms linking
early life exposures and later health. Besides these examples
of early disorganization of health for the rest of life, fetal life
is also a critical period due to occurrence of unique pro-
cesses such as brain development. As an example, disrup-
tion of thyroid hormone promotion of brain development
during fetal and early postnatal life has detrimental conse-
quences on lifelong intellectual abilities [14]. Overall, a
robust set of data concurs to support prioritization of preg-
nancy and early postnatal life for a healthy environment
[15, 16]. All those findings are consistent with the concept
of Developmental Origin of Health and Disease (DOHaD)
[17]. This concept was promoted by the observation that
impaired fetal growth, a reflection of intra-uterine exposure
to adverse conditions in the maternal environment, can be
predictive of adult metabolic malfunctioning [18, 19]. How-
ever, behind the different observations discussed here along
the DOHaD concept, different mechanisms can possibly be
involved and deserve studies in each specific condition.
Regulatory management of hazardous chemicals in the
European Union
The development of a regulatory framework for the man-
agement of chemical substances in the European Union
(EU) has been rightly viewed as a progress, hopefully con-
tributing to reduced exposures including in early life. For
example, REACH in 2006 [20] and the more recent regula-
tions for plant protection products in 2009 [21] and bio-
cidal products in 2012 [22] have provided the tools for
chemical’s risk management. While the health risk is a
function of exposure, the first step in a strategy of limiting
exposure is the identification of the hazard. The REACH
regulation, which applies since 2008, allows action under its
authorization regime: a hazardous substance can be in-
cluded in the candidate list, i.e. identified as of very high
concern (SVHC) and subsequently included in the so-
called “authorization” list, i.e. banned as of a sunset date
[23]. The data on these two regulatory actions [24, 25] indi-
cate that there is on average a 7-year time span between
the moment a substance has been identified as a SVHC
and the moment it is being phased out. This time span
however appears to increase with time (Fig. 1) as indicated
by the slopes of the regression lines which are significantly
different (F test, p < 0.0001). The time span is longer (F test,
p < 0.001) for substances identified as SVHCs in the period
2011–2013 (7.67 ± 1.41 yrs., mean ± SD) than 2008–2010
(6.46 ± 0.69 yrs). Between October 2008 and June 2013, 52
substances have been regulated as SVHC accounting for 10
chemicals regulated each year. The regulatory decision
about those 52 chemicals refers most frequently to carcino-
genicity (n = 28) and toxicity for reproduction (n = 14), not
excluding associated endocrine disrupting properties such
as observed with phthalates [11]. Also shown in Fig. 1,
there are 42 substances that have been identified as SVHCs
between December 2013 and July 2017 [25] but no
decision to phase them out has been taken so far
[24]. Time since registration was not considered in
this analysis since the date of registration was biased
by differences in both the criteria for registration and
time since marketing the substance.
The EU laws for identification and regulation of che-
micals have set a new scene for long debates between
stakeholders including industry, public authorities, non-
governmental organizations (NGOs) and scientists, among
others. A recent illustration is provided by the scientific
criteria for identification of EDCs [26, 27]. While the
current paradigm of management of individual hazardous
factors is a requirement and must be pursued, it is a very
slow process. So far, 1409 chemicals (last updated Septem-
ber 2017) have been listed as potential EDCs based on
data published in the peer-reviewed literature [28]. Since
this estimate does not include carcinogens and mutagens,
we hypothesize a likely underestimated figure of 1–2%
hazardous chemicals among the 145,297 chemicals listed
by ECHA as pre-registered before 2008 (last updated 11
August 2017). Based on the observed regulation of 10
chemicals per year under REACH and assuming a
similar figure for the chemicals not falling under
REACH, several generations would likely be needed
before the possible carcinogens, mutagens, repro-toxic
and EDCs are effectively regulated.
Presentation of the hypothesis
During the first half of the twentieth century, the imple-
mentation of a global anti-microbial hygiene led to an
important decrease in the morbidity and mortality of
infectious diseases, before the identification of most
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pathogenic microbial agents and the advent of antibi-
otics [29]. An analogous strategy, Environmental
Hygiene, a physical-chemical hygiene aiming at limita-
tion of exposure to hazardous agents, in particular mu-
tagenic agents and EDCs, is proposed here to reduce the
burden of those factors present in environment. We
hypothesize that, during prenatal and early postnatal life
as a priority period for intervention, a global protective
approach (Environmental Hygiene) could effectively
reduce some complex exposures. Consequently, adverse
health effects resulting from action of individual agents
as well as interactions among them could also be
reduced. It is hoped that such a global strategy will save
time and protect health while awaiting that a healthy
environment becomes a reality through the regulatory
measures. The suggested approach is consistent with the
precautionary principle and should involve regulatory
authorities and industry in information of the public and
the professionals towards equal opportunity access to
improved environmental health.
In Fig. 2, the sequence of events is schematically illus-
trated and compared in the current regulatory approach
of individual health hazards (Fig. 2, panel a) and in the
proposed strategy of Environmental Hygiene (Fig. 2,
panel b). As shown in panel a (Fig. 2), regulation identi-
fies different categories of health hazards e.g. mutagens,
EDCs, carcinogens and teratogens. In each category,
compounds or toxicants (D, E, F…) are considered indi-
vidually through their effects on a given system (X, Y, Z,
…) e.g. reproductive, thyroid/neurodevelopmental,
metabolic/obesogenic, as recommended by OECD [30].
A compound or toxicant can affect different systems
through involvement of different endpoints in each sys-
tem. The critical demonstration of causality is provided
by the study of one effect caused by one toxicant on one
endpoint in one system, individually. When sufficient
evidence has accumulated, risk assessment and manage-
ment of each particular compound or toxicant are per-
formed. Along the strategy of Environmental Hygiene
(Fig. 2, panel b), the hazardous factors, the adverse
effects, the intervention and the causality are addressed
globally. Considering exposure to health hazards as a
global condition is consistent with the exposure to envir-
onmentally relevant mixture of chemicals and the result-
ing interaction between chemicals and categories of
hazards e.g. chemicals and psychosocial stress. Evalu-
ation of the adverse effects as a whole can integrate
immediate and delayed effects in different systems
together. Here, the demonstration of causality is not a
prerequisite to a preventive intervention as a whole. The
concept is development of Environmental Hygiene for
global reduction of exposure to hazards. It is suggested
that an international panel of experts should develop
and endorse relevant and implementable protective mea-
sures. Their application is intended to be preferably as a
package of measures in order to maximize protection
from exposures and to minimize interactions among
hazards in causing adverse effects. The demonstration of
causality is meant to be a global and retroactive process.
Intervention studies are warranted with biomonitoring
Fig. 1 For each substance identified in the authorization list under REACH regulation, two dates are represented: when the substance was
identified as of very high concern (SVHC) candidate and the date of sunset i.e. when the substance has been or will be phased out following
the regulatory decision. The regression lines and the slopes ± Standard Error are shown. The slopes are significantly different (F test, p < 0.0001).
The data were retrieved from https://echa.europa.eu/authorisation-list and https://echa.europa.eu/candidate-list-table (accessed 15
September, 2017)
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and longitudinal evaluation of health endpoints in the
offspring. Based on the evidence obtained, the issue of
equal opportunity access to improved environmental
health will have to be addressed by authorities to make
health protection available to all pregnant women and
unborn children through action such as training of
health professionals and consumer information.
Implications of the hypothesis
Number of hazardous compounds and factors
The raising number of compounds to be evaluated in
each category of hazardous factors vastly out-pace scien-
tific studies about those compounds [1]. Despite efforts
towards development of high throughput tests for muta-
genicity and interaction of individual chemicals with dif-
ferent endocrine axes (e.g., reproduction, thyroid, energy
balance), data about many chemicals are completely
missing. Also, an approach “chemical by chemical” is
not consistent with the environmentally relevant expos-
ure to low-dose mixtures that account for complex
effects [31, 32]. Incorporation of those findings in the
decision-making process is challenging since the man-
agement of chemicals is meant to be one by one. An
emerging issue is also that different factors with different
modes of action can synergize and interact in causing
adverse effects [32]. An example is tumor promotion,
abundantly studied through in vivo experiments [33]
and possibly responsible for the human cancer risk after
multiple exposure involving dioxins and dioxin-like sub-
stances [34–36]. The concern of exposure to combin-
ation of chemicals raises several issues. At the very
beginning of life, synthetic chemicals from different
classes can be quantified already in cord blood and in
samples from pregnant women or of reproductive age
[37–39]. Overall, the fetus can be exposed to more than
300 chemicals. As analytical techniques improve, it is
expected that many more environmental chemicals will
be identified in human fluids and tissues. It is not known
how these chemicals interact and at what exposure levels
these combinations may pose health risks. Risk assess-
ment of combined exposures is on the agenda of the
European Commission who asked the European Food
Safety Authority (EFSA) to develop a strategy for asses-
sing health risks related to combined exposures [40].
One strategy is to group chemicals that belong to the
same chemical class such as PCB congeners or dioxins.
Chemicals can be grouped because they act on the same
target and form a cumulative assessment group as pro-
posed for pesticides by EFSA [41]. Alternatively expo-
sures may be concurrent when chemicals are present in
the same products. A more holistic approach is that
specific lifestyle, behaviors and environmental settings
may also lead to high exposures to a number of pollut-
ants and high risks in vulnerable groups such as the
Fig. 2 Two complementary paradigms for the management of factors hazardous to human health are illustrated. The current paradigm (panel a)
and the proposed additional paradigm (panel b) are schematically illustrated. Along the current strategy, the dashed arrows indicate that, based
on a single hazardous factor (D), different systems and adverse effects are considered (X, Y, Z, …), each deserving demonstration of causality
before risk is assessed and the hazardous factor managed. The approach of the issue as a whole is meant to reduce interactions among
hazardous factors, save time before hazard reduction and contribute to equal opportunity access to environmental health
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unborn, children or socio economic deprived subpopula-
tions. Possible combinations of adverse lifestyle factors
involve non-chemical hazards. For instance, exposure to
a stressful event during pregnancy can have cumulative
effects with chemicals [42, 43]. Thus, studies addressing
each factor one by one will often underestimate both
hazard and risk, signaling the requirement of more stud-
ies evaluating the effects of different factors together.
The proposed global strategy addresses different com-
pounds or factors as a whole. This approach is likely to
involve various hazardous chemicals or factors identified
in the environment (air, drinking water) and in consumer
products (e.g. food, drinks, home care and personal care).
Work environment should also be taken into account.
Identification of hazardous factors in relation with prod-
ucts and environmental conditions aims at building simple
recommendations that probably reduce exposure. This ap-
proach will address the issue of low-dose mixtures and
combination of different health hazards since application
of several protective measures as a package will likely
reduce the mechanistic interaction among the agents or
hazards. Chemical hygiene may be efficient to reduce mul-
tiple exposures in vulnerable groups.
Evaluation of adverse effects
The classical evaluation of adverse effects (as recom-
mended by OECD) considers the different systems sep-
arately i.e. male hormones (androgens), female hormone
(estrogens), thyroid hormones, hormones controlling
weight and glucose metabolism, etc. [30]. However, many
hazardous chemicals lack specificity of interaction and can
affect different parts of the endocrine system [11]. The
neuroendocrine effects of Bisphenol A provide an il-
lustration of the complexity and non-specificity of
adverse effects [44]. Importantly, the action of a
given hazardous factor on a given hormone in vivo
results in reactive changes in the same hormonal
system or axis (e.g. feedback mechanisms) and cross-
talking between different axes, e.g. leptin and
reproduction [45, 46]. Such mechanistic components
can be missed when addressing adverse effects using
components of the endocrine system one by one.
Along the proposed strategy, the adverse effects will be
addressed as a whole. This kind of approach is including
together different endpoints or outcomes that belong to
different systems. This multisystem approach emanci-
pates scientists and regulators from linking a single
chemical exposure to a single adverse outcome, and is
consistent with the reality of involvement of different
systems in the in vivo conditions of exposure to mix-
tures of hazardous factors. This includes the interaction
between hazardous factors in causing some effects as
well as the interaction between systems in explaining an
effect or a reaction to an effect.
Preventive intervention against hazardous factors
The central and original component in the proposed
global approach is preventive intervention against haz-
ardous factors as a whole that is not subordinate to thor-
ough demonstration of causal involvement of each
individual factor in adverse effects. Environmental
Hygiene aims at global reduction of exposure to hazards,
especially in pregnancy and early postnatal life. Imple-
mentation of Environmental Hygiene should start as
early as possible in pregnancy. Starting before pregnancy
would have been a preferable option because pre-
pregnancy health weighs significantly on pregnancy out-
comes and clearance of persisting pollutants. While such
an extension is worth being implemented in the future,
we have considered that the pregnant status is associated
with increased likelihood of changing consumer behaviors
in an initial phase and that focusing on pregnant women
would improve feasability. Recommendations aiming at
pregnancy have been published by Governmental agencies
e.g. the Danish Environment Protection Agency [47] or
non-governmental organizations. We suggest that an
international panel of experts should develop and endorse
the protective measures. The panel should be multidiscip-
linary including gynecology, pediatrics, endocrinology,
toxicology, public health and epidemiology among others.
Environmental Hygiene is meant to provide guidelines
validated by experts based on our current knowledge of
effects of individual hazardous factors. Preliminary studies
will have to show that they are implementable. Examples
of such measures are provided in Table 1. Specific com-
ments and references to each recommendation can be
found in the Additional file 1.
Demonstration of causality
In the regulatory management of chemicals one by one,
science is expected to provide the demonstration of
causal involvement of a given chemical before any meas-
ure is considered. Carrying the burden of proof is chal-
lenging since most human health disorders that are
possibly involving adverse effects of chemicals are multi-
factorial [11]. This, together with the exposure to chemi-
cals as mixtures, explains why only a limited fraction of
a given effect can be attributed to a given chemical. At-
tribution of a given effect to a mixture and elucidation
of the respective contribution of agents in the mixture
effect is even more challenging given the number of
compounds and the variety of mechanisms. Moreover,
for ubiquitous compounds, there is no unexposed popu-
lation that can provide an estimate of the “baseline”
prevalence of disease to which chemicals may contribute
an additional burden. Human epidemiology plays a crit-
ical role but carries severe limitations due to exposure to
mixtures, possibly long latency to effects, variability in
unintended level of exposure and negative confounding
Bourguignon et al. Environmental Health  (2018) 17:42 Page 5 of 11
due to exposure of the control population to other fac-
tors having the same effects, among other reasons.
While the generally agreed-upon WHO definition of
EDC [2, 11] states that the adverse effect is a conse-
quence of altered function of the endocrine system fol-
lowing exposure to the chemical (or mixture), the EU
Commission has introduced in the scientific criteria a
focus on the endocrine mode of action of which the
adverse effect is a consequence [48]. These requirements
undoubtedly will add to the delay in decision – making.
Diethylstilbestrol and PCBs were banned several decades
ago while our understanding of their mode of action was
minimal as compared to nowadays.
Along our proposed strategy, the demonstration of
causality is meant to be a retroactive process. Namely,
the proof of the causal role of the hazardous factors is
not a prerequisite to the global reduction of exposure.
Instead, demonstration of the favorable impact of the
global protective measures on the level of mother and
offspring exposure studied by biomonitoring together
with the effects on a number of health indicators will
provide evidence of global causality. An intervention is
substantiated by the numerous studies on the causal link
between a given factor and a given adverse effect. Inter-
vention studies are rather scarce such as a recent study
on the effect of dietary recommendations on exposure of
pregnant women to methyl mercury in Denmark [49].
While available studies on causal involvement of individ-
ual hazardous chemicals legitimate the global approach,
development of more intervention studies is desirable
though limited by ethical reasons and other factors such
as possible latency of decades between exposure and
Table 1 Some recommendations aiming at reduced exposure to health hazards during pregnancy and early postnatal life
Recommendations Targeted hazards
EDCs Mutagens Others
Everywhere Stop smoking tobacco and drinking alcohol x x x
Limit as much as possible passive smoking x x
Avoid frequent close presence to power lines; limit the use of cell phones or cordless mobile phones x
Limit the use of plastic or rubber toys and prefer products declared to be free of bisphenol A or
phthalates
x
Stay in a cool place in case of heat > 30 °C x
Personal care Restrict the use of cosmetics and lotions as much as possible x
Prioritize unscented products and stop using perfumes x
Do not color your hair; do not polish your nails x
Avoid tattoos x
Food and
drinks
Prioritize food and drinks from glass container instead of plastic bottles or metal cans x
Do not microwave food in plastic recipients x
Use quality-controlled water in glass bottles x x
Prioritize organic food whenever possible x x
Avoid processed, especially nitrite treated, meat x
Avoid charred meat and consumption of bread or other cereal products that are darkened due to high
temperature treatment
x
Limit (once a week) consumption of predator fish (tuna, swordfish, …) x x
Home care Wash new clothes before wearing them x x x
Avoid exposure to organic solvents x
Avoid as much as possible painting or coating (walls, doors, floors, …) x x
Avoid scented cleaning products, air fresheners and fragrances x x x
Clean inside the house using damp clothes and reduce dust x
Do not use insecticides x
Ventilate the bedrooms and living rooms at home for 10 min, 1–2 times a day x x
Outdoor Avoid the use of herbicides or pesticides x x
Close the car windows and recycle air while driving on highways, in tunnels and in heavy traffic x x
Prefer exercising in green areas and avoid heavily polluted air such as within 200 m of heavy traffic x x
Others Avoid exposure to medical x-rays unless really necessary x x
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effects. The mode of action does not appear to be a pre-
requisite in the global approach. Also, the intervention
does not aim at a given product from a given company
and intervention is not contingent upon demonstration
of causal involvement of a given chemical. However,
the possible demonstration of favorable effects on
health outcomes after reduced exposure to some haz-
ards through Environmental Hygiene will challenge
industry to demonstrate that chemicals that they pro-
duce are not involved.
Risk assessment and management
A final step in the classical management of hazardous
chemicals is risk assessment. Here, the dose is meant to
be critical in an attempt to define a so-called safe dose.
This approach is raising several issues including the pos-
sible gaps between in vitro models and in vivo condi-
tions, variations in sensitivity to chemicals depending on
endpoints and life periods as well as possible non-
monotonic dose-response relationship [26, 50]. All those
factors complicate the evaluation of risk and account for
additional time needed before regulatory decision.
Involvement of stakeholders towards the pregnant
woman as ultimate actor
The perspective and the implementation of Environmen-
tal Hygiene could unduly pressurize pregnant women. A
mother should not blame herself for poor outcomes that
must be attributed to collective negligence of industry,
policymakers and others. Conversely, safer outcomes
should result from mobilization of many stakeholders pro-
viding support and action towards women in pregnancy
as the ultimate actors. A strategy is proposed in Fig. 3. We
suggest that a task force binds together the different stake-
holders in developing support to the initiative. This
includes financial and technical means as well as em-
powerment of the different stakeholders in the different
actions required for implementation of Environmental
Hygiene. The next step consists of testing the hypothesis
through validation of the recommendations and studies
aiming at evidence that Environmental Hygiene can re-
duce exposure and protect health. These issues are ad-
dressed in the next section. The proposed strategy will
then lead to action towards equal opportunity access to
improved environmental health. The article 2 of the Treaty
on European Union [51] states « The Union is founded on
the values of respect for human dignity, freedom, democ-
racy, equality, the rule of law and respect for human
rights, including the rights of persons belonging to minor-
ities. These values are common to the Member States in a
society in which pluralism, non-discrimination, tolerance,
justice, solidarity and equality between women and men
prevail ». This substantiates action towards equal oppor-
tunity access to improved environmental health. Provided
that scientific studies validate the benefits of a global
approach, policymakers will have to ensure that access to
Fig. 3 Implementation of Environmental Hygiene. A task force involving the different stakeholders is proposed and provides support to the
initiative including financial, technical and any other aspects. The task force clarifies the role of stakeholders in subsequent action including
validation of recommendations aiming at protection of pregnant and lactating mothers from environmental hazards and setting up studies
aiming at evidence of reduced exposure and health protection in the offspring. Based on those studies, the task force endorses and enforces
the strategy of Environmental Hygiene that must be made available to all. The next steps are professional education of health care providers
and consumer information, with pregnant women and their life circle as ultimate actor
Bourguignon et al. Environmental Health  (2018) 17:42 Page 7 of 11
Environmental Hygiene is not limited by educational,
socio-economic or any other characteristic of subpopula-
tions [52]. For instance, proper information of consumers
about the composition of products will be critical. This is
a regulatory issue implying that labeling is consistent with
composition, readable and understandable. Moreover,
education of health care providers, particularly those tak-
ing care of pregnant women and young children,
should be developed in terms of both content and in-
formation tools [53]. The key of that management
proposal is the individual citizen i.e. the individual
pregnant woman and young parents who deliberately
become players for the protection of their offspring
and possibly next generations.
Environmental Hygiene will be conducted in conjunc-
tion with the current management of individual hazard-
ous chemicals by regulatory authorities. This process
aims at banning or restricting the use of a given chem-
ical. The resulting benefits can take decades due to data
gaps required to prove causation, time consuming ex-
perimental or epidemiological work, debates between
stakeholders and persistence of some chemicals in the
environment among other reasons. The regulatory
evaluation of chemicals remains however a keystone in
the management of hazards and risks threatening public
health. It is therefore critical that policymakers take any
suitable measures that can speed up the process of
chemical safety assessment and management. The regu-
latory process is beyond the control of individual citizens
and health care providers and may dismiss preventive
management, a feeling reinforced by discordant informa-
tion about the impact of chemicals on human health,
and insufficient education. Industry also has a crucial
role in the quality of raw materials used in the prepar-
ation of consumer products. This is essential for the
presence or absence of hazardous chemicals [5]. This
issue is beyond the awareness of consumers including
pregnant women and advisers such as health care pro-
fessionals. Awareness requires transparent and readable
information about constituents in consumer products.
Therefore, industry has a very important initial role that
must be implemented and monitored by authorities.
The issues of Environmental Hygiene far transcend
Europe. They have been addressed globally by WHO in
a recent publication [54]. WHO points to emerging en-
vironmental hazards including chemicals as a threat to
children’s health and proposes a precautionary approach
to protecting children from the effects of chemicals. This
important work is symbiotic with our hypothesis and
legitimates extension of the efforts to a global scale.
Testing the hypothesis and concluding remarks
Environmental Hygiene is proposed as a global strategy
aiming at protection of pregnant women, unborn children
and infants against hazardous factors as a whole. Three
research questions can be identified about the proposed
strategy and must be addressed by scientists with financial
support from public authorities: 1. What could be consen-
sual and implementable protective measures in pregnancy
and lactation? 2. What is the evidence that those protective
measures reduce exposure to hazardous chemicals? 3.
What is the evidence that those protective measures im-
prove health? Implementation of such studies will have to
address several issues including selection of recommenda-
tions, monitoring of exposure to hazards and health out-
comes. The panel of experts will have to identify the
criteria used for selection of the relevant recommendations.
These criteria should incorporate the likelihood of reduced
exposure through the proposed measure as well as the
applicability based on the psychosocial characteristics of the
study population. Questionnaires and interviews will be
crucial for assessment of consumer behaviours before and
during the study. The parameters selected for biomonitor-
ing of exposure before and during the study will depend on
baseline consumer behaviours, access to biological material
and reliability of measurements among other factors. Inev-
itably, the studied population will be heterogeneous as far
as the baseline consumer behaviours and exposures. Infor-
mation on the efficacy of individual protective measures
can come out of well-designed observational studies in a
population of pregnant women. They could be stratified for
specific lifestyles that they plan before or in early pregnancy
and that they effectively embrace during pregnancy. These
data could be used for the purpose of comparison with an
intervention study using Environmental Hygiene as a pack-
age of measures. Inclusion of a control group is likely not
feasible because everyone is exposed to some hazards and
for ethical reasons. Some questions arise from the likely
differences in risk awareness and health impact among the
consumer behaviors. For example, the very serious conse-
quences of fetal exposure to mother smoking and drinking
alcohol and the public awareness about those issues may
justify that refraining from smoking and drinking alcohol is
an inclusion criterion in all the study groups. The inclusion
criteria should be selected to maximize the chance of
demonstrating the effects on exposure and health out-
comes. An example is a short term intervention study of
exposure to BPA and phthalates where the selected subjects
were those reporting the most frequent use of canned foods
[55]. The recruitment of subjects is challenging as shown in
a study on reduction of mercury exposure in pregnant
women [56]. These authors were able to enrol 8% or 36%
of the women contacted by mail or directly approached on
the ward before a scan, respectively. The investigators will
have to motivate the participants, for instance through the
feedback on exposures before and after implementation of
Environmental Hygiene. Over the past 10 years, birth
cohorts embraced the wave of new omics technologies to
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allow and understand the molecular pathways from expos-
ure towards disease prevention. Environmental Hygiene in
early life will benefit from omics as a tool to address causal-
ity along with the aforementioned classical concepts, even
on the basis of observations. Based on the results of such
studies, all stakeholders could endorse Environmental
Hygiene and the strategy should become accessible to all.
Such an objective will need joint action of academies,
regulatory authorities and NGOs towards education of
health care providers and consumer information.
The production of many environmental hazards arises
out of economic activity, and the consequences of Envir-
onmental Hygiene cannot be ignored. While government
inaction is often justified out of a concern that regula-
tory measures can stunt economic growth, the economic
benefits are likely to be great, given the substantial dis-
ease burden that can be prevented by reducing exposure.
Endocrine disruptor-related diseases are well known to
contribute costs on the order of 1.2 and 2.3% of Gross
Domestic Products in Europe and the US, respectively
[57]. Among these costs, mixtures of EDCs were identi-
fied as contributors to disease-related costs, and a global
approach is likely to maximize the economic impacts.
Relevant exposures are also known to cluster by routes
and categories of exposure (e.g., food packaging, pesti-
cides), and a single contaminant approach is less likely
to maximize effects on hormonal pathways (e.g., thyroid)
that are particularly important.
Environmental Hygiene can by no means substitute
for regulatory management restricting or banning chem-
ical use. Such a regulatory approach is indispensable to
protect public health in the long term and to reduce
detrimental effects of chemicals on animal and plant
biodiversity. However, Environmental Hygiene calls for
additional involvement of regulatory authorities in infor-
mation and education of consumers and professionals
towards global protective behaviors and equal opportun-
ity access to improved environmental health.
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